LON:OBI Ondine Biomedical (OBI) Share Price, News & Analysis → His win rate puts Warren Buffett to shame… (From Investing Daily) (Ad) Free OBI Stock Alerts GBX 5.75 -0.20 (-3.28%) (As of 05:12 AM ET) Add Compare Share Share Today's Range 5.75▼ 5.8850-Day Range 5.88▼ 10.3352-Week Range 5.50▼ 20.40Volume22,130 shsAverage Volume261,593 shsMarket Capitalization£13.04 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsHeadlinesStock AnalysisChartCompetitorsHeadlines Get Ondine Biomedical alerts: Email Address Ad Investing DailyHis win rate puts Warren Buffett to shame… Not long ago I joined Phil Ash for a private one-on-one interview. And during our time together I pulled the covers of my investing system that’s delivered 779 winners and 43,509% total profits since November of 2015… Without a single loss.Click here now for the full story. About Ondine Biomedical Stock (LON:OBI)Ondine Biomedical Inc., a Life sciences company, engages in the research, development, and commercialization of antimicrobial photodisinfection therapies in Canada and internationally. Its product platform is Photodisinfection, a topical light-based antimicrobial technology that eliminates harmful pathogens. The company's lead product is Steriwave, a photodisinfection-based medical device that eliminates harmful nasal pathogens, which leads to healthcare-associated infections. Its product pipeline also includes development of a topical antiviral therapy for the upper respiratory tract that reduces viral titres and transmission of respiratory viruses, such as SARS-CoV-2, influenza, RSV, etc.; a solution for treatment of chronic rhinosinusitis; a solution for disinfection of endotracheal tubes to reduce the incidence of ventilator-associated pneumonia; and a solution for decolonization of burns and wounds. The company was incorporated in 1996 and is headquartered in Vancouver, Canada.Read More OBI Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart OBI Stock News HeadlinesApril 25, 2024 | uk.finance.yahoo.comOndine Biomedical Inc Announces New Study Confirms Nose Is Key Source of InfectionApril 24, 2024 | uk.finance.yahoo.comOndine Biomedical Inc Announces Corporate and Trading UpdateApril 29, 2024 | Investing Daily (Ad)His win rate puts Warren Buffett to shame… Not long ago I joined Phil Ash for a private one-on-one interview. And during our time together I pulled the covers of my investing system that’s delivered 779 winners and 43,509% total profits since November of 2015… Without a single loss.April 22, 2024 | uk.finance.yahoo.comOndine Biomedical Inc Announces Steriwave in First Australian HospitalApril 21, 2024 | americanbankingnews.comOndine Biomedical (LON:OBI) Hits New 52-Week Low at $6.50April 15, 2024 | uk.finance.yahoo.comOndine Biomedical Inc. Announces 32% Fewer SSIs After Steriwave Replaced MupirocinApril 10, 2024 | uk.finance.yahoo.comOndine Biomedical Inc. Announces Steriwave Authorized for use by HCA UKApril 4, 2024 | uk.finance.yahoo.comOndine Biomedical Inc. Announces Entry into ICU Market Expands Revenue PotentialApril 29, 2024 | Investing Daily (Ad)His win rate puts Warren Buffett to shame… Not long ago I joined Phil Ash for a private one-on-one interview. And during our time together I pulled the covers of my investing system that’s delivered 779 winners and 43,509% total profits since November of 2015… Without a single loss.March 27, 2024 | finance.yahoo.comOndine Biomedical achieves milestone with NHS trust's adoption of SteriwaveMarch 25, 2024 | uk.finance.yahoo.comOndine Biomedical Inc. Announces First commercial adoption of Steriwave by the NHSFebruary 1, 2024 | lse.co.ukOndine Biomedical touts efficacy of Steriwave post presenting researchJanuary 27, 2024 | lse.co.ukOndine Biomed Share ChatDecember 5, 2023 | proactiveinvestors.comOndine secures £2.75m of new fundingNovember 16, 2023 | uk.movies.yahoo.comOndine Biomedical Inc Announces Photodisinfection Recommended as Standard of CareNovember 13, 2023 | finance.yahoo.comOndine Biomedical’s nasal photodisinfection named as leading photonics biomedical technology for its potential to safely combat AMRNovember 9, 2023 | uk.finance.yahoo.comOndine Biomedical Inc. (OBI.L)November 6, 2023 | finance.yahoo.comOndine Biomedical’s Steriwave platform seeing strong adoptionOctober 31, 2023 | uk.movies.yahoo.comOndine Biomedical Inc Announces Steriwave use Expanded Following Successful PilotOctober 27, 2023 | lse.co.ukOndine Biomed Regulatory NewsOctober 13, 2023 | uk.style.yahoo.comOndine Biomedical Inc. - Steriwave now in Canada's East CoastOctober 13, 2023 | proactiveinvestors.comOndine Biomedical share price soars after Canadian hospital adopts SteriwaveOctober 6, 2023 | investing.comOndine Biomedical Inc (OBI)September 29, 2023 | uk.finance.yahoo.comOndine Biomedical Inc. Announces Burnaby Hospital deploys SteriwaveSeptember 21, 2023 | uk.style.yahoo.comOndine Biomedical Inc. Announces Montreal Heart Institute pilots SteriwaveSeptember 20, 2023 | finance.yahoo.comOndine’s nasal photodisinfection therapy (APDT) improves short-term and long-term immune response while significantly reducing SARS-CoV-2 infectivitySeptember 20, 2023 | finance.yahoo.comOndine Biomedical’s Nasal Photodisinfection Reduces Hospital Length of Stay, Readmissions and Antibiotic Use in Substantial Study at Major Ottawa HospitalSee More Headlines Receive OBI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Ondine Biomedical and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolLON:OBI CUSIPN/A CIKN/A Webwww.ondinebio.com Phone604-669-0555FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX (0.06) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income£-18,700,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-144.07% Return on Assets-70.25% Debt Debt-to-Equity Ratio24.39 Current Ratio2.34 Quick Ratio8.26 Sales & Book Value Annual Sales£856,000.00 Price / Sales15.23 Cash FlowGBX 2.89 per share Price / Cash Flow1.99 Book ValueGBX 2 per share Price / Book2.88Miscellaneous Outstanding Shares226,750,000Free FloatN/AMarket Cap£13.04 million OptionableNot Optionable Beta-0.14 These 7 Stocks Will Be Magnificent in 2024With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.Get This Free Report Key ExecutivesMs. Carolyn M. Cross C.F.A.CFA, M.B.A., MBA, Founder, CEO & Executive DirectorDr. Nicolas G. Loebel Ph.D.President, CTO & Executive DirectorDr. Simon Sinclair Ph.D. (Age 52)Chief Medical Officer & Director Comp: $73.39kMr. Kwong Choo CPACIMA, Interim Chief Financial OfficerMr. William KanzSenior VP of Engineering & OperationsAngelika VanceVice President of Corporate CommunicationsMr. Matt RossVice President of Sales & MarketingMs. Elaine Lei CPACorporate ControllerMore ExecutivesKey CompetitorsNetScientificLON:NSCIOptiBiotix HealthLON:OPTISynairgenLON:SNGRealm TherapeuticsLON:RLMSkinBioTherapeuticsLON:SBTXView All Competitors OBI Stock Analysis - Frequently Asked Questions How have OBI shares performed in 2024? Ondine Biomedical's stock was trading at GBX 8.75 at the beginning of 2024. Since then, OBI stock has decreased by 32.1% and is now trading at GBX 5.95. View the best growth stocks for 2024 here. How do I buy shares of Ondine Biomedical? Shares of OBI stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:OBI) was last updated on 4/29/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsHis win rate puts Warren Buffett to shame… Investing DailyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBiden out June 13; Kamala won’t replace him?Paradigm PressMan Who Predicted 2008: “This Will be Worse.”AltimetryJeff Bezos Just Humiliated Elon MuskInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ondine Biomedical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
